Uniting biological toolkits for a new approach to ALS
What happened
DeepMind researchers have developed a new approach to treating Amyotrophic Lateral Sclerosis (ALS) by combining insights from biology and machine learning. This approach uses a 'biological toolkit' to identify potential treatments for ALS, which could lead to more effective and personalized therapies. The method has shown promising results in early tests, offering new hope for ALS patients.
Why it matters
This breakthrough demonstrates the potential of interdisciplinary research and the application of AI in medical science, paving the way for more innovative approaches to complex diseases.
Is this a big deal?
Get stories like this every morning
The day's AI news in plain English, in your inbox at 8:30 IST. Free.
More from Google
Google Search gets a major upgrade with Gemini 4 HydrogenGoogle · 12 Nov 2026Introducing Gemini 4 HydrogenGoogle · 12 Nov 2026Gemini 4 HydrogenGoogle · 12 Nov 2026Gemini Decisions API: Fast, calibrated multimodal decisionsGoogle · 11 Nov 2026Try Tabletop: Customizable, collaborative spaces for groups to plan, play and do more together.Google · 11 Nov 2026This page was collected from deepmind.google and summarised automatically by AIPulsee's pipeline. See how it runs.